The evolution of CAR T-cell therapy
Steven T. Rosen
Can daratumumab be used to treat refractory MM?
What we can look forward to in the world of non-Hodgkin lymphoma
Immune checkpoint inhibitors and their role in MM: pembrolizumab and durvalumab
Assessment of response in MM: challenges and advances